1. Home
  2. KOD vs PBPB Comparison

KOD vs PBPB Comparison

Compare KOD & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOD
  • PBPB
  • Stock Information
  • Founded
  • KOD 2009
  • PBPB 1977
  • Country
  • KOD United States
  • PBPB United States
  • Employees
  • KOD N/A
  • PBPB N/A
  • Industry
  • KOD Biotechnology: Biological Products (No Diagnostic Substances)
  • PBPB Restaurants
  • Sector
  • KOD Health Care
  • PBPB Consumer Discretionary
  • Exchange
  • KOD Nasdaq
  • PBPB Nasdaq
  • Market Cap
  • KOD 259.6M
  • PBPB 305.0M
  • IPO Year
  • KOD 2018
  • PBPB 2013
  • Fundamental
  • Price
  • KOD $3.60
  • PBPB $10.62
  • Analyst Decision
  • KOD Hold
  • PBPB Strong Buy
  • Analyst Count
  • KOD 3
  • PBPB 3
  • Target Price
  • KOD $9.00
  • PBPB $15.33
  • AVG Volume (30 Days)
  • KOD 419.7K
  • PBPB 186.6K
  • Earning Date
  • KOD 05-14-2025
  • PBPB 05-07-2025
  • Dividend Yield
  • KOD N/A
  • PBPB N/A
  • EPS Growth
  • KOD N/A
  • PBPB 1009.90
  • EPS
  • KOD N/A
  • PBPB 1.39
  • Revenue
  • KOD N/A
  • PBPB $465,126,000.00
  • Revenue This Year
  • KOD N/A
  • PBPB $4.74
  • Revenue Next Year
  • KOD N/A
  • PBPB $4.48
  • P/E Ratio
  • KOD N/A
  • PBPB $7.61
  • Revenue Growth
  • KOD N/A
  • PBPB N/A
  • 52 Week Low
  • KOD $1.92
  • PBPB $6.28
  • 52 Week High
  • KOD $11.60
  • PBPB $13.48
  • Technical
  • Relative Strength Index (RSI)
  • KOD 49.07
  • PBPB 66.51
  • Support Level
  • KOD $3.46
  • PBPB $9.75
  • Resistance Level
  • KOD $3.81
  • PBPB $10.80
  • Average True Range (ATR)
  • KOD 0.42
  • PBPB 0.29
  • MACD
  • KOD -0.05
  • PBPB 0.05
  • Stochastic Oscillator
  • KOD 46.20
  • PBPB 82.86

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

About PBPB Potbelly Corporation

Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.

Share on Social Networks: